← back to healthcare-npi-new-registrant-feed
Financial analysis · adoption-ready estimate
Healthcare NPI New-Registrant Feed ·
If an entrepreneur "adopted" this product today, here's the realistic math.
Fermi summary
If you land 55 subscribers at $175/mo that's $115k ARR - but with free CMS data undercutting you and IQVIA overhead-ing you, there's maybe a 16% shot you get there, making expected year-1 take-home negative after build costs.
Market size (TAM)
$6.2M
~3,100 realistic buyers (healthcare staffing firms, medical device sales teams, EHR vendors, billing companies, insurance prospectors) × $167/mo avg × 12 months - constrained heavily by free NPPES data availability
Year-1 ARR range
$22k - $360k
midpoint $115k
Investment to production
$28k
Dev: $14k for automated NPPES ingestion pipeline, filtering UI, API delivery, and billing. Enrichment: $4k for phone/address append on NPI r
Probability of success
16%
P(reaching mid case in 12 months)
Expected take-home Y1
$-11980
probability-weighted, after investment
Go-to-market motion
Cold email + LinkedIn outbound to VP Sales at medical device companies and healthcare staffing agency owners - pitch early-mover prospect lists for new practitioners entering their target specialties, targeting 40 demos/month → 4 closes/month at $175 avg MRR.
Key risks
- NPPES data is free from CMS - sophisticated buyers already download it themselves or buy richer data from Definitive Healthcare/IQVIA at $10-50k/yr, making $150/mo feel redundant rather than cheap
- Subscriber churn is structural: buyers download the new-registrant list, work it for 90 days, then cancel - recurring revenue assumption breaks if retention is 4-6 months not 12
- Specialty and geography filtering only matters if the data is clean and enriched; NPI records often have incomplete or stale contact info, requiring expensive append workflows that eat margin
Generated by the Wishdeal Factory financial-analysis agent. Numbers are honest Fermi estimates, not guarantees. Real outcomes depend on the operator. The studio is bullish on the engineering quality, agnostic on the business outcome.